Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

21-12-2015 | Original Paper

Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review

Auteurs: Seema Jain, Rebecca Andridge, Jessica A. Hellings

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 4/2016

Abstract

Loxapine substitution is a promising option for patients with autism spectrum disorder (ASD) who develop antipsychotic-induced metabolic illness. We performed a chart review of 15 adolescents and adults meeting DSM-IV-TR criteria for ASD, all with antipsychotic-associated weight gain, who received low dose loxapine in an attempt to taper or discontinue the weight gain-associated antipsychotic. Mean weight loss was −5.7 kg, mean BMI reduction was −1.9, and mean triglyceride reduction was −33.7 mg/dl. At chart review, 14 of 15 subjects were rated 2 (Much Improved) or 1 (Very Much Improved) on the Clinical Global Impressions-Improvement scale (CGI-I). Low dose loxapine addition in most cases enabled taper of offending antipsychotics, significantly reversed drug-induced metabolic disturbances and improved irritability.

vorige artikel Perceived Friendship Quality of Children with Autism Spectrum Disorder as Compared to their Peers in Mixed and Non-mixed Dyads

volgende artikel Alexithymia in Adolescents with Autism Spectrum Disorder: Its Relationship to Internalising Difficulties, Sensory Modulation and Social Cognition

Alvarez-Jimenez, M., Hetrick, S. E., Gonzalez-Blanch, C., Gleeson, J. F., & McGorry, P. D. (2008). Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomized controlled trials. British Journal of Psychiatry, 193, 101–107.CrossRefPubMed

Aman, M. G., & Singh, N. N. (1986). Aberrant behavior checklist: Manual. East Aurora, NY: Slosson Educational Publications.

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorder, Fourth Edition revised. Arlington, VA: American Psychiatric Association.CrossRef

Beherec, L., Lambrey, S., Quilici, G., Rosier, A., Falissard, B., & Guillin, O. (2011). Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors. Journal of Clinical Psychopharmacology, 31(3), 341–344.CrossRefPubMed

Bobo, W. V., Cooper, W. O., Stein, C. M., Olfson, M., Graham, D., Daugherty, J., et al. (2013). Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry, 70(100), 1067–1075.CrossRefPubMed

Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., et al. (2011). Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473(7346), 221–225.CrossRefPubMedPubMedCentral

Brooks, J. O., Chang, H. S., & Krasnykh, O. (2009). Metabolic risks in older adults receiving second-generation antipsychotic medication. Current Psychiatry Reports, 11, 33.CrossRefPubMed

Campbell, M., Anderson, L. T., Meier, M., Cohen, I. L., Small, A. M., Samit, C., et al. (1978). A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 17(4), 640–655.CrossRefPubMed

Correll, C. U., Robinson, D., Schooler, N., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., et al. (2014). Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: Baseline results from RAISE-ETP study. JAMA Psychiatry, 71(12), 1350–1363.CrossRefPubMed

Doss, F. W. (1979). The effect of antipsychotic drugs on body weight: A retrospective review. Journal of Clinical Pyschiatry, 40, 528.

Goudie, A. J., Cooper, G. D., & Halford, J. C. G. (2005). Antipsychotic-induced weight gain. Diabetes, Obesity and Metabolism, 7(5), 478–487.CrossRefPubMed

Guy, W. (1976). Clinical Global Impression scale (CGI). The ECDEU Assessment Manual for Psychopharmacology-Revised, 76(338), 218–222.

Hellings, J. A., Jadhav, M., Jain, S., Jadhav, S., & Genovese, A. (2015a). Low dose loxapine: neuromotor side effects and tolerability in autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 25(8), 618–624.CrossRefPubMed

Hellings, J. A., Reed, G., Cain, S. E., Zhou, X., Barth, F. X., Aman, M. G., et al. (2015b). Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability. Journal of Child and Adolescent Psychopharmacology, 25(2), 150–159.CrossRefPubMedPubMedCentral

Hellings, J. A., Zarcone, J. R., Crandall, K. C., Wallace, D., & Schroeder, S. R. (2001). Weight gain in a controlled study of risperidone in children, adolescents, and adults with mental retardation and autism. Journal of Child and Adolescent Psychopharmacology, 11, 229–238.CrossRefPubMed

Jibson, M. D. (2014). First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects. In R. Herman (Ed.), UptoDate Waltham, MA. (Accessed June 17, 2014).

Li, Z., Ichikawa, J., & Meltzer, H. Y. (2003). A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens. Psychopharmacology (Berl), 167(3), 315–323.

Lieberman, J. A., & Stroup, T. S. (2011). The NIMH-CATIE Schizophrenia Study: What did we learn? American Journal of Psychiatry, 168(8), 770–775.CrossRefPubMed

Lynch, T., & Price, A. (2007). The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. American Family Physician, 76(3), 391–396.PubMed

Mizuno, Y., Suzuki, T., Nakagawa, A., Yoshida, K., Mimura, M., Fleischhacker, W. W., et al. (2014). Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: A systematic review and meta-analysis. Schizophrenia Bulletin, 40(6), 1385–1403.CrossRefPubMedPubMedCentral

Munetz, M. R., & Benjamin, S. (1988). How to examine patients using the Abnormal Involuntary Movement Scale. Psychiatric Services, 39(11), 1172–1177.CrossRef

Newcomer, J., & Haupt, D. (2006). The metabolic effects of antipsychotic medications. Canadian Journal of Psychiatry, 51, 480–491.PubMed

Pramyothin, P., & Khaodhiar, L. (2010). Metabolic syndrome with the atypical antipsychotics. Current opinion in Endocrinology, Diabetes, and Obesity, 17(5), 460–466.CrossRefPubMed

Reinblatt, S. P., Abanilla, P. K., Jummani, R., & Coffey, B. (2006). Loxapine treatment in an Autistic child with aggressive behavior: Therapeutic challenges. Journal of Child and Adolescent Psychopharmacology, 16(5), 639–643.CrossRefPubMed

Stahl, S.M. (2002). Essential psychopharmacology of antipsychotics and mood stabilizers. Cambridge: Cambridge University Press.

Stahl, S. M. (2007). Essential psychopharmacology: The prescriber’s guide. New Delhi: Cambridge University Press.

Wetterling, T., & MuBigbrodt, H. E. (1999). Weight gain: Side effect of atypical neuroleptics? Journal of Clinical Psychopharmacology, 19(4), 316–321.CrossRefPubMed

Wu, R. R., Zhao, J. P., Jin, H., Shao, P., Fang, M. S., Guo, X. F., et al. (2008). Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain. JAMA, 299, 185–193.PubMed

Titel: Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review
Auteurs: Seema Jain
Rebecca Andridge
Jessica A. Hellings
Publicatiedatum: 21-12-2015
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 4/2016
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-015-2675-3

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2016

Editorial: 2015 in Review

W. Solomon, C. Holland, M. J. Middleton: Autism and Understanding: The Waldon Approach to Child Development

Gender Differences in the Social Motivation and Friendship Experiences of Autistic and Non-autistic Adolescents

Factors Associated with Subjective Quality of Life of Adults with Autism Spectrum Disorder: Self-Report Versus Maternal Reports

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder

A Meta-analysis of the Wisconsin Card Sort Task in Autism